These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Negative selection of herpes simplex virus thymidine kinase in Toxoplasma gondii. Fox BA; Belperron AA; Bzik DJ Mol Biochem Parasitol; 2001 Aug; 116(1):85-8. PubMed ID: 11463470 [No Abstract] [Full Text] [Related]
5. Cloning of the herpes simplex virus type 1 thymidine kinase gene in E. coli K 12: a selective marker for gene transfer into animal cells. Colbere-Garapin F; Horodniceanu F; Kourilsky P; Garapin AC Dev Biol Stand; 1980; 46():75-82. PubMed ID: 6245004 [TBL] [Abstract][Full Text] [Related]
6. A dominant positive and negative selectable gene for use in mammalian cells. Schwartz F; Maeda N; Smithies O; Hickey R; Edelmann W; Skoultchi A; Kucherlapati R Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10416-20. PubMed ID: 1720540 [TBL] [Abstract][Full Text] [Related]
7. The viral thymidine kinase gene as a tool for the study of mutagenesis in Trypanosoma brucei. Valdés J; Taylor MC; Cross MA; Ligtenberg MJ; Rudenko G; Borst P Nucleic Acids Res; 1996 May; 24(10):1809-15. PubMed ID: 8657559 [TBL] [Abstract][Full Text] [Related]
8. Replication inhibition by nucleoside analogues of a recombinant Autographa californica multicapsid nuclear polyhedrosis virus harboring the herpes thymidine kinase gene driven by the IE-1(0) promoter: a new way to select recombinant baculoviruses. Godeau F; Saucier C; Kourilsky P Nucleic Acids Res; 1992 Dec; 20(23):6239-46. PubMed ID: 1335569 [TBL] [Abstract][Full Text] [Related]
9. New selectable markers and single crossover integration for the highly versatile Plasmodium knowlesi transfection system. Wel Av; Kocken CH; Pronk TC; Franke-Fayard B; Thomas AW Mol Biochem Parasitol; 2004 Mar; 134(1):97-104. PubMed ID: 14747147 [TBL] [Abstract][Full Text] [Related]
10. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer. Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475 [TBL] [Abstract][Full Text] [Related]
11. New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions. Karreman C Nucleic Acids Res; 1998 May; 26(10):2508-10. PubMed ID: 9580709 [TBL] [Abstract][Full Text] [Related]
12. Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir. Prasmickaite L; Høgset A; Olsen VM; Kaalhus O; Mikalsen SO; Berg K Cancer Gene Ther; 2004 Jul; 11(7):514-23. PubMed ID: 15118758 [TBL] [Abstract][Full Text] [Related]
13. In vivo drug-selectable markers in gene therapy. Sugimoto Y; Tsuruo T Leukemia; 1997 Apr; 11 Suppl 3():552-6. PubMed ID: 9209454 [TBL] [Abstract][Full Text] [Related]
14. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir. Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841 [TBL] [Abstract][Full Text] [Related]
15. Selectable markers for the transfer of genes into mammalian cells. Colbére-Garapin F; Garapin A; Kourilsky P Curr Top Microbiol Immunol; 1982; 96():145-57. PubMed ID: 6276089 [No Abstract] [Full Text] [Related]